Pharmaceutical Composition With Synergistic Anticonvulsant Effect - EP2037965

The patent EP2037965 was granted to Schwarz Pharma on Aug 30, 2017. The application was originally filed on Jun 15, 2007 under application number EP07764676A. The patent is currently recorded with a legal status of "Revoked".

EP2037965

SCHWARZ PHARMA
Application Number
EP07764676A
Filing Date
Jun 15, 2007
Status
Revoked
Dec 20, 2019
Grant Date
Aug 30, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCAREMay 30, 2018TER MEER STEINMEISTER & PARTNER -

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTEP1541138
INTERNATIONAL-SEARCH-REPORTUS5378729
INTERNATIONAL-SEARCH-REPORTUS5773475
INTERNATIONAL-SEARCH-REPORTWO2006079547
OPPOSITIONUS2007042969

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- PROSSER H M ET AL, "Epileptogenesis and enhanced prepulse inhibition in GABA-B1-deficient mice", MOLECULAR AND CELLULAR NEUROSCIENCES, SAN DIEGO, US, (20010601), vol. 17, doi:10.1006/MCNE.2001.0995, ISSN 1044-7431, pages 1059 - 1070, XP002968373
INTERNATIONAL-SEARCH-REPORT- FOUNTAIN N B ET AL, "ABSENCE OF EFFECT OF ADJUNCTIVE SPM 927 ON CONCOMITANT AED PLASMA CONCENTRATIONS IN SUBJECTS WITH PARTIAL SEIZURES", MOLECULAR IMMUNOLOGY, ELMSFORD, NY, US, (20031205), vol. 44, no. SUPPL. 09, ISSN 0161-5890, page 96, XP009028153 [X] 1-39 * abstract *-
INTERNATIONAL-SEARCH-REPORT- HORSTMANN R ET AL, "SPM 927 DOES NOT INTERACT WITH VALPROIC ACID AND CARBAMAZEPINE", MOLECULAR IMMUNOLOGY, ELMSFORD, NY, US, (20031205), vol. 44, no. SUPPL. 09, ISSN 0161-5890, page 97, XP009028152 [X] 1-39 * abstract *-
INTERNATIONAL-SEARCH-REPORT- REYNOLDS E H ET AL, "SINGLE DRUG OR COMBINATION THERAPY OF EPILEPSY?", DRUGS, ADIS INTERNATIONAL LTD, (19810101), vol. 21, no. 5, ISSN 0012-6667, pages 374 - 382, XP009029147 [Y] 1-39 * the whole document *
OPPOSITION- JATUZIS D. et al., "Evaluation of the Effect of oral Lacosamide on concomitant AED Plasma Concentrations on Patients with partial Seizures", Epilepsia (AES Proceedings), (20050000), vol. 46, no. 8, page 170, XP055492673-
OPPOSITION- BIALER et al., "Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)", Epilepsy Research, (20010100), vol. 43, no. 1, pages 11 - 58, XP002267163
OPPOSITION- LUSZCZKI J. J. et al., "Interactions of Lamotrigine with Topiramate and First- generation Antiepileptic Drugs in the Maximal Electroshock Test in Mice : An Isobolographic Analysis", Epilepsia, (20030000), vol. 44, no. 8, pages 1003 - 1013, XP055492662
OPPOSITION- DECKERS C. L. P. et al., "Selection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence Reviewed", Epilepsia, (20000000), vol. 41, no. 11, pages 1364 - 1374, XP009035157
OPPOSITION- LUSZCZKI J. J. et al., "Pharmacodynamic and Pharmacokinetic Characterization of Interactions between Levetiracetam and Numerous Antiepileptic Drugs in the Mouse Maximal Electroshock Seizure Model: An Isobolographic Analysis", Epilepsia, (20060000), vol. 47, no. 1, pages 10 - 20, XP055492666

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents